Active ingredientPadsevonilCat. No. P-P003-001CAS 1294000-61-5Family · Pharmaceutical analytical standards
Padsevonil
An investigational antiepileptic studied in the late 2010s for drug-resistant focal epilepsy: in 2020 a phase 2b trial did not meet its main goals. This family brings together the active ingredient.
Did you know?It was designed to act on both sides of the synapse: it binds the synaptic vesicle proteins SV2A, SV2B and SV2C and, on the other side, the benzodiazepine site of the GABA-A receptor.
Go to the active ingredient →Active ingredientPadsevonilCat. No. P-P003-001CAS 1294000-61-5No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.